$AXON

SMITH PATRICK W sold $5.0M of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 10,000 shares of AXON ENTERPRISE, INC. (AXON) at $500.00 ($5.00M total) on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Jun 30, 2026, 8:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The CEO’s open-market sale is disclosed with a stated 10b5-1 pre-arranged plan, which generally lowers informational content about near-term business risk.

02

Market read

This is a disclosed insider sale; it may cause brief sentiment noise but is unlikely to drive a fundamental repricing by itself.

03

What to watch

Traders may still watch for follow-on insider activity (additional sales/buys) or whether the sale size is unusual relative to prior Form 4 patterns, which are not provided here.

Relevance 5/10Novelty 5/10Timing: after-hours/filing timestamp (2026-06-30) for a 2026-06-29 sale disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon CEO Smith Patrick W filed a Form 4 open-market sale of 10,000 shares at ~$500.0018 on 2026-06-29 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a disclosed insider transaction with a pre-arranged 10b5-1 plan, which reduces the probability the sale reflects new negative information.

Market effects

Minimal; insider selling at a single company does not materially reset sector fundamentals.

Minimal; no broader regional catalyst indicated.

Minimal; transaction is company-specific and not tied to global events.

Counterpoint

Because it’s a 10b5-1 plan, the sale may be purely mechanical (tax/liquidity) and should not be over-weighted versus operating fundamentals.

Key entities

  • AXON

    Axon Enterprise, Inc., issuer of the Form 4 insider transaction.

  • SMITH PATRICK W

    Chief Executive Officer and director who sold shares under a 10b5-1 plan.

Related articles

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12